Biosimilar medicine fact sheet – tocilizumab

This fact sheet provides information about a biosimilar brand of tocilizumab listed on the Pharmaceutical Benefits Scheme (PBS).

About this resource

Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English

Tocilizumab is a biological medicine listed on the PBS which is used to treat a range of conditions such as active giant cell arteritis, severe active juvenile idiopathic arthritis, severe active rheumatoid arthritis and systemic juvenile idiopathic arthritis.

On 1 October a biosimilar brand of this medicine was listed on the PBS.

Tags: